xXTomcatXx
xXTomcatXx
xXTomcatXx

The South African delivered the bladerunners boats to Iran this way.

Relax, butkus. It was a joke. Obviously, you can’t fire upon another country’s military in international waters without provocation.

You can’t be serious. That argument goes out the window when you make this claim:

I was thinking of something similar.

Awful attempt at a point. The Russians do it constantly. The Chinese don’t posses power projection so they can’t (not yet at least). Give it 5 more years and you’ll be reading all about it.

“Imagine if China was flying recon flights out of Cuba?”

The US builds bases in host nation’s territory with that nations approval, and they do it for security reasons. China does it against ALL nations wishes for economic gain. It’s not like the US is drilling in the SCS.

You’ll have to let me know what the US economic gains of Guam, Diego Garcia, Bahrain, or Ramstein are. China wants to setup a military base in Venezuela? Fine (assuming Venezuela’s cool with it). The US has no problem leaving their allies’ homeland whenever a host country deems their presence unwanted (see the Navy’s

“The R&D is already done but a new formulation still has to make it through clinical, which is expensive.”

These other drugs aren’t generic equivalents, but rather treatment alternatives. So I’m not sure insurance companies can really do anything here. Like requiring a generic in it’s place. The problem here is that the culture is for doctors to rely heavily on Dexaprim. What incentive do they have to risk these other

It’s not generic, as generics are under completely different regulations. His company simply purchased the production and marketing from Impax. And the FDA doesn’t grant exclusivity when a market is handed over from one company to another. In this case they’re still selling Deraprim they’re not manufacturing a

I’m referring to the right to market that Turing Pharma purchased from Impax. Not patents. Obviously this has been out of patent for decades. Turing basically paid for Impax to stop production and the acquisition of non-protected IP. The problem with raising the prices as much as they have is that suddenly a market

Actually, in addition to Pyrimethamine (this guy’s drug) there are the following acute Toxoplasmosis treatments:

Agreed, for the most part. Except there should be a conversation had on drug rights. A generic version should have been on the market years ago.

Lol! That guy was mesmerized by his little noisemaker. It sums up the attention span of a Bills fan.

Sure it’s a smart play, but Russia’s been very adamant that after Libya they won’t let the West bamboozle them again. Russia holds grudges, I wouldn’t expect this to suddenly break that trend.

Sharp tie, John.

I have trouble pointing the finger at any one person, personally. I mean this program has gone through two presidents, FOUR SecDefs, Countless Program Managers, and several rounds of congressional supporters. It’s as if the program itself had a mind of its own. I think at this point (and for quite some time now) the

It’s not always a business management pipe-dream. I would argue that it’s often a product of the evolving threat and unwillingness to invest early in acquisition programs.